Skip to content

Eli Lilly LLY Total Equity

Total Equity at other companies

Pfizer logo
PfizerPFE
$90.1B-0.3%
Amgen logo
AmgenAMGN
$9.19B+48.1%
Cardinal Health logo
Cardinal HealthCAH
-$2.83B+3.9%
Mannkind logo
MannkindMNKD
-$59.2M-1.0%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$486.72M+33.4%
McKesson logo
McKessonMCK
-$2.17B-4.7%

Other financials

Income statement

See full
Revenue$19.8B+55.5%
Gross profit$16.2B+54.4%
Net income$7.4B+168%
EPS (diluted)$8.26+170%

Balance sheet

See full
Cash & equivalents$5.3B+70.8%
Total debt$43.4B+12.6%
Total assets$116.58B+30.4%

Cash flow

See full
Operating cash flow$5.3B+220%
CapEx$2.3B+54.0%
Free cash flow$3.0B+1,828%

Valuation

See full
Market cap$1.09T+56.4%
Enterprise value$1.12T+53.8%
P/E42.9×-7.3×
P/S15×+2.0×

Profitability

See full
Gross margin82.8%+1.1pp
Net margin35%+12.3pp
FCF margin16.4%+8.7pp

Returns & leverage

See full
Return on equity107.6%+29.9pp
Debt / equity1.4×-1.1×
Current ratio1.5×+0.1×

Where this comes from

Reported directly by Eli Lilly in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eli Lilly's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eli Lilly's total equity?
Eli Lilly (LLY) reported total equity of $31.2B in Q1 2026.
How has Eli Lilly's total equity changed year-over-year?
Eli Lilly's total equity increased by 97.9% year-over-year, from $15.76B to $31.2B.
What is the long-term trend for Eli Lilly's total equity?
Over 5 years (2020 to 2025), Eli Lilly's total equity has grown at a 36.3% compound annual growth rate (CAGR), from $5.64B to $26.54B.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.